Showing results (171-180 of 189) with videos related to
Sort By:
Pageof 19
Vaccine|May 25, 2017
Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infantsNicola P Klein, Remon Abu-Elyazeed, Matthew Cornish, et al.Dermatology and Therapy|December 4, 2012
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1Bruce E Strober, Jennifer Clay Cather, David Cohen, et al.Journal of Biological Regulators and Homeostatic Agents|April 14, 2015
Western blot expression of 5-lipoxygenase in the brain from striped dolphins (stenella coeruleoalba) and bottlenose dolphins (tursiops truncatus) with or without encephalitis/meningo-encephalitis of infectious natureG Di Guardo, A Falconi, A Di Francesco, et al.Journal of the American Academy of Dermatology|June 17, 2009
A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approachBruce Strober, Emily Berger, Jennifer Cather, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 23, 2022
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2A P Fernandez, E Dauden, S Gerdes, et al.Journal of Endocrinological Investigation|August 17, 2023
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitorsS Antonini, R Pedersini, M F Birtolo, et al.Journal of the American Academy of Dermatology|February 11, 2011
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions, Alan Menter, Neil J Korman, et al.Journal of the Pediatric Infectious Diseases Society|January 8, 2017
Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled TrialVarsha K Jain, Joseph B Domachowske, Long Wang, et al.The New England Journal of Medicine|June 15, 2016
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque PsoriasisKenneth B Gordon, Andrew Blauvelt, Kim A Papp, et al.Dermatology and Therapy|December 23, 2018
Clinical Goals and Barriers to Effective Psoriasis CareBruce E Strober, Joelle M van der Walt, April W Armstrong, et al.Pageof 19